NO20074885L - N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus - Google Patents

N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus

Info

Publication number
NO20074885L
NO20074885L NO20074885A NO20074885A NO20074885L NO 20074885 L NO20074885 L NO 20074885L NO 20074885 A NO20074885 A NO 20074885A NO 20074885 A NO20074885 A NO 20074885A NO 20074885 L NO20074885 L NO 20074885L
Authority
NO
Norway
Prior art keywords
respiratory syndrome
syndrome virus
porcine reproductive
protein mutants
virus
Prior art date
Application number
NO20074885A
Other languages
English (en)
Inventor
Dongwan Yoo
Changhee Lee
Jay Gregory Calvert
Siao-Kun Welch
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20074885L publication Critical patent/NO20074885L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C12N2770/10062—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Oppfinnelsen angår et genetisk modifisert PRRS-virus og polynukleotider som koder for dette. Vaksiner omfattende det genetisk modifiserte virus og polynukleotider er også frembrakt.
NO20074885A 2005-02-25 2007-09-25 N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus NO20074885L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65652305P 2005-02-25 2005-02-25
US73066305P 2005-10-27 2005-10-27
PCT/IB2006/000376 WO2006129139A1 (en) 2005-02-25 2006-02-13 N protein mutants of porcine reproductive and respiratory syndrome virus

Publications (1)

Publication Number Publication Date
NO20074885L true NO20074885L (no) 2007-11-22

Family

ID=36218763

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074885A NO20074885L (no) 2005-02-25 2007-09-25 N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus

Country Status (15)

Country Link
US (3) US7544362B1 (no)
EP (1) EP1856141A1 (no)
JP (1) JP4320357B2 (no)
KR (2) KR100996105B1 (no)
CN (1) CN101128478B (no)
AR (1) AR052392A1 (no)
AU (1) AU2006253891B2 (no)
BR (1) BRPI0606189A2 (no)
CA (1) CA2599322C (no)
MX (1) MX2007009060A (no)
NO (1) NO20074885L (no)
NZ (1) NZ561848A (no)
RU (1) RU2381035C2 (no)
TW (1) TWI366602B (no)
WO (1) WO2006129139A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006253891B2 (en) * 2005-02-25 2011-12-01 Zoetis P Llc N Protein Mutants of Porcine reproductive and respiratory syndrome virus
US8969536B2 (en) * 2008-10-16 2015-03-03 Zoetis Llc Torque teno virus (TTV) isolates and compositions
US8846388B2 (en) 2009-10-16 2014-09-30 Zoetis Llc Infectious clones of torque teno virus
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
JP6096176B2 (ja) 2011-05-27 2017-03-15 シノヴェット （ベイジン） バイオテクノロジー カンパニー，リミテッド ブタウイルス感染の予防のための混合ワクチン
US20140286980A1 (en) 2011-06-08 2014-09-25 Zoetis Llc Infectious clones of torque teno virus
WO2012174220A1 (en) * 2011-06-14 2012-12-20 Globeimmune, Inc. Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
WO2013163337A1 (en) * 2012-04-24 2013-10-31 The Ohio State University Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
KR102012109B1 (ko) * 2012-05-17 2019-08-19 조에티스 엘엘씨 이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
KR102402645B1 (ko) * 2020-01-29 2022-05-26 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 변이주 및 이를 포함하는 백신 조성물
KR102276341B1 (ko) * 2020-01-29 2021-07-12 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 제조 방법 및 이의 용도
WO2021154055A1 (ko) * 2020-01-29 2021-08-05 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 변이주 및 이를 포함하는 백신 조성물
CN114315984B (zh) * 2021-12-29 2023-02-03 中国农业科学院兰州兽医研究所 一种用于制备prrsv基因ii型表位缺失疫苗毒株的n蛋白表位突变标记及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
NZ501264A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS
CA2366072C (en) * 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
CN1406277A (zh) * 2000-01-26 2003-03-26 贝林格尔·英格海姆维特梅迪卡有限公司 Prrsv的重组减毒
EP1421184A2 (en) * 2001-03-09 2004-05-26 Boehringer Ingelheim Vetmedica Gmbh Live attenuated strains of prrs virus
EP1397498A1 (en) * 2001-05-21 2004-03-17 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Delections in arterivirus replicons
AU2006253891B2 (en) * 2005-02-25 2011-12-01 Zoetis P Llc N Protein Mutants of Porcine reproductive and respiratory syndrome virus

Also Published As

Publication number Publication date
US8128937B2 (en) 2012-03-06
CN101128478B (zh) 2013-08-14
KR20100090311A (ko) 2010-08-13
CA2599322C (en) 2013-09-03
JP2008531006A (ja) 2008-08-14
RU2007131536A (ru) 2009-03-27
JP4320357B2 (ja) 2009-08-26
NZ561848A (en) 2010-02-26
CN101128478A (zh) 2008-02-20
US20090130143A1 (en) 2009-05-21
US20090226486A1 (en) 2009-09-10
TWI366602B (en) 2012-06-21
BRPI0606189A2 (pt) 2009-06-09
EP1856141A1 (en) 2007-11-21
AU2006253891A1 (en) 2006-12-07
WO2006129139A1 (en) 2006-12-07
US7544362B1 (en) 2009-06-09
US20100136051A1 (en) 2010-06-03
AR052392A1 (es) 2007-03-14
KR100996105B1 (ko) 2010-11-22
CA2599322A1 (en) 2006-12-07
TW200641126A (en) 2006-12-01
RU2381035C2 (ru) 2010-02-10
MX2007009060A (es) 2007-09-11
KR20070095453A (ko) 2007-09-28
AU2006253891B2 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
DK1951882T3 (da) Nukleinsyrer, der koder for vacciner mod porcint reproduktions- og respirationssyndromvirus (PRRSV)
BRPI0510674A (pt) variantes fc otimizadas
HUE042561T2 (hu) Anti-IL-23-ellenanyagok, készítmények, eljárások és alkalmazások
NO20080246L (no) Anti-IGF1R-antistofformuleringer
ATE465176T1 (de) Il-7-varianten mit reduzierter immunogenität
GB2438802A (en) Structure of the hepatitis C virus NS5A protein
EA200702643A1 (ru) Антитела, связывающие tweak
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
DK1797281T3 (da) Fremgangsmåde til at estimere et bruds geometri, såvel som sammensætninger og artikler anvendt dertil
DK1776011T3 (da) Fungicid sammensætning, indeholdende et syreamidderivat
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
ITMI20021897A1 (it) Seggiolone con dondolo per bambini.
DK1255815T3 (da) Porcint reproduktivt og respiratorisk syndromvirus til fremgangsmåder til anvendelse
UA97369C2 (ru) Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе
DE602004016894D1 (de) Umschlagsdeformation mittels unterteilten Oberflächen
TW200641126A (en) N protein mutants of porcine reproductive and respiratory syndrome virus
EP1794329A4 (en) ISOLATES OF PIG VIRUS CAUSING REPRODUCTION AND RESPIRATORY SYNDROME AND THEIR USE
NO20065115L (no) Cellulaer tillatende faktor for virus, og anvendelse derav
BRPI0607692A2 (pt) peptìdeos para detecção de anticorpo para o vìrus da sìndrome reprodutiva e respiratória suìna
PL1833508T3 (pl) Szczepy świńskiego wirusa zespołu rozrodczo-oddechowego i ich kompozycje
EP1940438A4 (en) STABILIZED GLP-1 ANALOGUES
DE602005007364D1 (de) Peptidcyclisierung
MX2009003300A (es) Vectores de rhinovirus recombinantes.
NO20072578L (no) Mutant svinereproduktivt og respiratorisk syndromvirus
NO20090395L (no) Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application